Phenominer Database Results (11 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
WOKW body mass index (BMI) control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. body mass female 224.0 days 12 0.62 g/cm2 body weighing method 0.0 67913 251
WOKW serum high density lipoprotein cholesterol level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood HDL cholesterol amount female 196.0 days-224.0 days 12 serial mean 57.92 mg/dl serum high-density lipoprotein-cholesterol measurement test ophthalmic venous plexus Roche Cobas Mira Plus (Roche, Switzerland) average of measures taken at 196 days, 210 days and 224 days 12424 251
WOKW serum triglyceride level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood triglyceride amount female 196.0 days-224.0 days 12 serial mean 292.04 mg/dl automated blood analysis ophthalmic venous plexus 0.0 Roche Cobas Mira Plus (Roche, Switzerland) average of measures taken at 196 days, 210 days and 224 days 12423 251
WOKW serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood insulin amount female 196.0 days-224.0 days 12 serial mean 0.0 mg/dl radioimmunoassay ophthalmic venous plexus 0.0 Roche Cobas Mira Plus (Roche, Switzerland) average of measures taken at 196 days, 210 days and 224 days 67919 251
WOKW blood glucose level area under curve (AUC) glucose solution (2 g/kg) Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood glucose amount female  days 12 11127.27 (mg/dl) x min intraperitoneal glucose tolerance test tail vein 0.0 intraperitoneal injection 60 min glucose analyser (Medingen ESAT 6660-2, Germany) samples taken at 0, 10, 30, 60 minutes 13272 251
WOKW serum leptin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood leptin amount female 196.0 days-224.0 days 12 serial mean 3.6 ng/ml radioimmunoassay ophthalmic venous plexus 0.0 Roche Cobas Mira Plus (Roche, Switzerland) average of measures taken at 196 days, 210 days and 224 days 67917 251
WOKW serum total cholesterol level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood cholesterol amount female 196.0 days-224.0 days 12 serial mean 84.94 mg/dl serum total cholesterol measurement test ophthalmic venous plexus Roche Cobas Mira Plus (Roche, Switzerland) average of measures taken at 196 days, 210 days and 224 days 12425 251
WOKW serum triglyceride level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood triglyceride amount female 196.0 days-224.0 days 12 serial mean 44.25 mg/dl automated blood analysis ophthalmic venous plexus 0.0 Roche Cobas Mira Plus (Roche, Switzerland) average of measures taken at 196 days, 210 days and 224 days 12428 251
WOKW body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. body mass female 210.0 days 12 255.0 g body weighing method 0.0 12398 251
WOKW blood glucose level glucose solution (2 g/kg) Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. blood glucose amount female  days 12 91.0 mg/dl intraperitoneal glucose tolerance test 0.0 intraperitoneal injection min glucose analyser (Medingen ESAT 6660-2, Germany) average of measures taken at 196 days, 210 days and 224 days 13271 251
WOKW both inguinal fat pads weight to body weight ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. inguinal fat pad mass female 224.0 days 12 1.5 % post excision weight measurement 0.0 both sides fat pads to bw ratio 67915 251